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Background: We have recently investigated the localisation of immunoglobulin-producing cells (IPCs) in inflamed
intestinal tissue samples from patients with inflammatory bowel disease (IBD), and identified two main patterns of B
lymphocyte infiltration: one characterised by the moderate strong stromal localisation of small B1 cell-like IgM
+/CD79+/CD20-/CD21-/CD23-/CD5 ± IPCs, and the other by the peri-glandular localisation of IPCs with irregular
nuclei that had surface markers specific for a B cell subset (IgM and CD79), but quantitative differences in their λ
and κ chains. The same patients were also tested for CD15+ receptors, which were localised on inflammatory cell
surfaces or in the crypts of the intestinal epithelium. CD15+ receptor distribution in inflamed tissues was limited to
the cell structures. The aim of the study was to analyse variations in IPCs and CD15+ cell morphology or
distribution in bowel biopsy specimens taken from patients with pre-malignant polyps or adenocarcinomas.
Methods: IPCs were analysed by means of immunofluorescence using polyclonal goat anti-human μ chains. The
pre-malignant polyp specimens were tested for B cell surface phenotype λ and κ chains, CD79, CD20, CD21 and
CD23 using an immunoperoxidase method. CD15+ cells were evaluated using the immunoperoxidase method and
monoclonal anti-CD15 IgM.
Results: The study involved 14 patients (four with pre-malignant polyps and 10 with colorectal adenocarcinomas).
The distribution of μ chains and CD15 markers varied in all of the biopsies, but delineated normal cell structures in
the pre-malignant polyp specimens. B cell surface phenotype analysis of μ chain-positive cells identified a subset of
CD79+/CD20-/CD21-/CD23- IPCs. The IPCs in certain areas showed the sporadic disintegration of inflammatory cell
membranes or the accumulation of fluorescence in individual cells. IPC membrane disintegration was particularly
marked in all of the adenocarcinoma samples, in which the CD15 markers also showed epithelial cell involvement.
Furthermore, six of the ten adenocarcinoma samples had atypical and reorganised membranes that expressed an
excess of both receptors and isolated small portions of tissue within the tumour.
Conclusion: The findings of this preliminary morphological study suggest the presence of membrane
disintegration and remodelling mechanisms in the tumours. The newly-formed membranes expressed high
concentrations of inflammatory cell receptors that can confer adhesive properties.
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A number of studies have shown that the origin of cancer
may lie in chronic inflammation, and that inflammation
is a critical component of tumour progression [1]. De
Visser et al. [2] have shown that B lymphocytes play a
critical role in initiating chronic inflammation during
pre-malignancy, thus supporting the idea that, although
important, oncogene expression in “initiated” cells is not
solely responsible for malignant progression. The B1 cell
subset of B lymphocytes, which are mainly present in the
pleural and peritoneal cavities, can migrate to inflamma-
tory sites and differentiate into mononuclear phagocytes
with macrophage-like phenotypes [3]. They also secrete
numerous antibodies against common membrane phos-
pholipids, such as phosphatidylcholine [4]. Various au-
thors have shown a physical interaction between the B16
murine melanoma cell line and B1 cells in experimental
co-cultures [5,6]. The same authors evaluated the inter-
action between B1 and tumour cells in order to investi-
gate whether this gives rise to signals that influence
melanoma cell metastases, and observed cell-to-cell in-
teractions due to adhesive molecules expressed on the
surfaces of both types of cells. The expression of a high-
molecular-weight mucin-like sialoglycoprotein positively
correlates with progression to metastatic phenotypes.
Electrophoretic separation of tumour tissue extract on 3%
polyacrylamide gel followed by direct staining with the FH6
monoclonal antibody has shown that the glycoproteins of
the highest molecular weight contained sialyl-LewisX, the
CD15 antigen, and mucins. Selectins are adhesive receptors
that normally recognise some vascular mucin-type glyco-
proteins bearing the carbohydrate sialyl-LewisX structure,
and facilitate leukocyte rolling in blood vessels. P-selectin
deficiency reduces tumour growth and metastases in mice
treated with a receptor antagonist peptide [7]. We have re-
cently investigated the localisation of immunoglobulin-
producing cells (IPCs) in inflamed intestinal tissue samples
from 96 patients with inflammatory bowel disease (IBD:
64 with ulcerative colitis [UC] and 32 with Crohn’s disease
[CD]), and identified two main patterns of B lymphocyte
infiltration. One (42.7% of the cases) was characterised by
the moderate-strong stromal localisation of small B1 cell-
like IgM+/CD79+/CD20-/CD21-/CD23-/CD5: IPCs [8],
and the other (35.4% of the cases) by the peri-glandular
localisation of IPCs with irregular nuclei that had surface
markers specific for a B cell subset (IgM and CD79), but
quantitative differences in their λ and κ chains. The same
96 patients were also tested for CD15+ receptors, which
were localised on inflammatory cell surfaces or in the
crypts of the intestinal epithelium [9]. The aim of this
study was to evaluate the distribution of μ chains and
CD15+ receptors in biopsy specimens of pre-malignant
polyps and adenocarcinomas in order to identify marker
distribution in a tumoral context.Methods
Patients
Four intestinal pre-malignant polyps and ten colorectal
adenocarcinoma tissue samples were taken from patients
undergoing complete colonoscopy at Fatebenefratelli
Hospital in Milan, Italy, all of whom signed an informed
consent form in accordance with the Declaration of
Helsinki. The study was approved by the Ethics Committee
of Fatebenefratelli Hospital. The diagnoses were confirmed
by means of standard endoscopic and histological criteria
(additional hematoxylin and eosin staining). Six sections of
each biopsy specimen were taken from premalignant and
neoplastic foci and analysed. Control specimens were taken
from ten patients with normal endoscopic results, and
without any macroscopic signs of inflammatory or neoplas-
tic disease.
Immunofluorescence method
The intestinal sections (3 μm) were deparaffined (72°C)
and pre-treated to enhance antigenicity (95°C × 36 min),
and the tissue distribution of the μ chains was investigated
using indirect immunofluorescence (IIF). The sections
were incubated with horse serum for 30 minutes at room
temperature in order to prevent non-specific binding.
After removing the blocking solution, the sections were
incubated with a goat anti-human IgM diluted 1:100
(μ chain-specific, Vector Laboratories, Burlingame, California,
USA, code FI-3020 ). While being protected from expos-
ure to direct light at 37°C for one hour, the samples were
washed four times for five minutes in high salt PBS (NaCL
4 M and PO4 buffer) and mounted. Images of four ran-
domly selected areas of each sample were recorded at 20×
and 40× magnification (Eurostar Instruments, Lubeck,
Germany).
Immunoperoxidase method
The pre-malignant polyp and colorectal adenocarcinoma
specimens were deparaffined (72°C), and pre-treated to
enhance antigenicity at a specific temperature and/or
time of incubation. Immunoperoxidase was used to de-
tect the distribution of the tissue expression of CD15.
The premalignant polyp sections (3 μm) were also used
to detect λ and κ chains, CD79, CD20, CD21 and CD23.
The murine monoclonal antibody (mAb) λ and κ chains,
CD15, CD79, CD20, CD21 and CD23 (Medical System,
Tucson, Arizona, USA) were applied to formalin fixed,
paraffin-embedded tissue using a Ventana automated slide
stainer (Medical System), after which the biotinylated sec-
ondary antibodies were added, followed by the streptavidin-
horseradish peroxidase conjugate (the anti-CD was diluted
for use with Ventana detection kits and automated slide
stainers). Each step in the staining protocol included incu-
bation for a precise period of time at a specific temperature.
At the end of each incubation step, the sections were rinsed
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to halt the reaction and remove any unbound material that
would hinder the desired reactions in subsequent steps. A
coverslip solution was used in the slide stainer in order to
minimise the evaporation of the aqueous reagents from
the specimen-containing slide. The complex was then
visualised using a hydrogen peroxide substrate and 3, 3’-
diaminobenzidine tetrahydrochloride (DAB) chromogen.
Results
Study population
The demographic and histological characteristics of the
14 fourteen patients are shown in Table 1.
Fluorescent anti-μ chain marker localisation in pre-
malignant polyps identified B cells with a low
cytoplasmic/nuclear ratio
The staining of the pre-malignant polyp biopsies showed a
striking invasion of small peri-glandular IgM-positive cells
with a low cytoplasmic/nuclear ratio in the hyperplastic in-
testinal mucosa (Figure 1a). However, there were morpho-
logical modifications in some zones, and the irregular
distribution of anti-μ chain fluorescence seemed to indicate
the initial disintegration of IPC membranes (Figure 1b)
or an accumulation of fluorescence in individual IPCs
(Figure 1c and c’).
B cell surface phenotype analysis of μ chain-positive cells
identified a subset of λ and κ chain positive, CD79
+/CD20-/CD21-/CD23- IPCs in pre-malignant polyps
B cell-specific surface molecules were examined in the
four polyp samples, all of which were positive for CD79
and κ and λ chains. This finding was confirmed by IIF.
All of the samples were negative for the three other spe-
cific markers of the B2 subset: CD20 (a mature B cell-
specific molecule), CD23 and CD21. Morphology and
phenotype analyses indicated that these cells were simi-












Severeten normal small intestinal, colonic and rectal biopsy
specimens, which suggests they contribute to the physio-
logical intestinal cell population.
Anti-μ chain marker localisation in colorectal
adenocarcinomas identified B cell membrane fragments
Six of the ten adenocarcinoma samples showed a loss in
the integrity of lymphocytic cell membranes, and the
fluorescent anti-μ chain marker was either distributed
across membrane segments (Figure 1d) or concentrated
on irregular membranous structures. These newly-formed
membranes isolated small tissue portions within the tu-
moral context (Figure 1e). Morphologically, the fragments
of membrane seemed to come from small B1-like cells
with a low cytoplasmic/nuclear ratio, which had lost their
nuclei and were distributed around the gland-like struc-
tures. Within the same biopsy stainings, fluorescent anti-μ
antibodies also revealed very thick, irregular and stratified
articulated membranes that completely enclosed portions
of neoplastic tissue. Their peripheral zones showed persist-
ent membrane fragments whose morphology indicated they
came from B1-like cells. The remaining four samples
contained IgM-positive cells with irregular nuclei that were
sporadically distributed and had a peri-glandular localisation
(Figure 1f). These cells were not detected in the normal
control tissue. The samples also showed the progressive dis-
solution of lymphocytic membranes. The fluorescent anti-μ
chain marker was distributed around glandular structures in
a fragmentary manner (Figure 1g). No IPC membrane re-
modelling was detected in these samples.
CD15 marker distribution within the pre-malignant
polyps indicated epithelial and inflammatory cell integrity
In the pre-malignant polyps, the CD15 marker was
localised on the surface of glandular cells or on inflam-
matory cells sporadically infiltrating the peri-glandular
zone (Figure 1h). The intercellular matrix clearly showed




















Figure 1 Morphological distribution of μ chains in a pre-malignant polyp revealed by means of indirect immunofluorescence
(magnification 40x). The IPC structures were regularly delineated and, unlike conventional plasma cells, had a low cytoplasmic/nuclear ratio.
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indicated epithelial cell membrane disintegration
The CD15 marker on the adenocarcinoma stainings indi-
cated the disintegration of both inflammatory and epithe-
lial cell membranes (Figure 1i). The integrity of the cells
and the intercellular space was lost, and there was an ir-
regular accumulation of the CD15 marker in circumscribed
tissue areas (Figure 1j).
Discussion
The findings of this morphological study indicate that
IPCs and CD15+ cells were present in the neoplastic
foci, and participated in the local transformations. The μ
chain-positive IPCs in the premalignancy polyps were
small CD79+/CD20-/CD21-/CD23- lymphocytes with a
low cytoplasmic/nuclear ratio. They therefore had a sur-
face phenotype that is unrelated to mature B cells and
seemed to represent a distinct subset of B1-like IPCs.
These cells had the same morphological aspects and
membrane markers of IPCs found in 42.7% of the IBD pa-
tients involved in our previous study [8]. However, unlike
the findings in the IBD samples, there were circumscribed
areas in which anti-μ chain fluorescence was irregularly
distributed, which may indicate initial membrane disinte-
gration. There was also an accumulation of fluorescence
on the membrane surface of individual IPCs that suggests
probable reactivity against tissue component. In patients
with IBD, the CD15 marker is regularly expressed on epi-
thelial and inflammatory cells, and the integrity of the cell
membranes is maintained, and this was observed in the
polyp samples despite the presence of epithelial hyperpla-
sia. On the contrary, the CD15 marker revealed epithelial
and inflammatory cell fragments indicating the disintegra-
tion of both in all of the adenocarcinoma specimens. The
findings of an increasing number of studies suggest that
stromal cells play a significant role in the process of tumour
invasion [10]. The CD15-positive fragments occupied
the intercellular matrix, thus suggesting that the alter-
ation may have caused the subversion of normal mem-
brane disposition. In vitro and in vivo models have
shown that anti-tumour antibodies mediate tumour inva-
sion and metastasis by processes that include extracellular
matrix degradation and angiogenesis [11]. Matrix metal-
loproteinase 2 (produced particularly by inflammatory cells)
[12] and matrix metalloproteinase 7 (encoded by epithelial
cells) are both involved in the degradation of extracellular
matrix components, and have been related to carcinogen-
esis and metastasis in patients with colorectal cancer [13].
The increased activity of matrix metalloproteinases in aden-
omas appears to be a biomarker of early tumorigenesis
[14]. In six of the ten adenocarcinoma biopsy stainings, the
μ chains had lost their normal disposition but could be
recognised on membrane segments. Morphologically, it
seemed that the μ chain-positive segments came from B1-like cells. In previous studies [8,9], we have found B1-like
cells in normal and inflammatory intestinal tissue, and in
polyps. These cells therefore live on intestinal mucosa, and
their number may increase during the inflammatory
process. Neoplastic transformation changes their morph-
ology somewhat in polyps but markedly in adenocarcin-
omas, to the point that they lose their structural integrity.
These findings suggest that the immunoglobulins detected
in the neoplastic lesions did not come from circulating
cells or a remote control mechanism. It therefore seems
that there is no deposition of immunoglobulins in adeno-
carcinomas [15], but a loss of the integrity of resident cells
expressing IgM. The same six adenocarcinoma biopsy
stainings showed membrane remodelling and the over-
expression of μ chains and CD15 receptors, which was
identified as atypical membrane remodelling arising from
isolated tissue portions. This was not found in the previ-
ously evaluated sections of normal or inflamed intestinal
tissue and polyps. On the basis of the images, we believe
that these tissue islands are generated by a membrane fu-
sion mechanism, and that the μ chains and CD15 marker
acquired in this remodelling process give the newly-
formed membranes adhesive properties. As the CD15
receptor mediates adhesion to vascular walls [16] and
antiphosphatidylcholine antibodies are directed against
components of normal cell membranes [17], we hypothe-
sise that the concentration of these receptors in restricted
tissue areas can increase tissue adhesion in vessel walls
and cell membranes, and thus induce metastases. Studies
of the associations between cell surface molecules and the
metastatic behaviour of tumour cells in humans have
shown that the activity of the collagenolytic enzymes pro-
duced and secreted by tumour tissues has no correlation
with metastatic potential, but that the expression of a
high-molecular-weight mucin-like sialoglycoprotein posi-
tively correlates with progression to metastatic phenotypes
[18,19]. Furthermore, studies of the induction of metasta-
ses in B cell knockout and B cell-depleted mice have
shown that there a reduction in tumour growth and me-
tastases when B cells are absent or impaired [11]. How-
ever, the remaining four of our tumour samples showed
the infiltration of IgM-positive cells with irregular nuclei.
These cells infiltrated the tissue in a sporadic manner and
were often fragmented (which complicates their additional
characterisation), but their microscopic appearance is very
particular and identified the same cells previously ob-
served in 35.7% of an IBD population [9]. The cells had
lost their structural integrity, but there was no membrane
remodelling. The fluorescent marker of immunoglobulin
was scarce, had a peri-glandular disposition and affected
the partial demarcation of tumoral tissue. We therefore
suggest that the presence of different types of IPCs in tu-
moral transformation foci can influence the behaviour of
malignant tumours, and the number and quality of the
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shown that the size of primary tumours with synchronous
hepatic metastases is not significantly different from that of
non metastatic tumours, which suggests that certain tu-
mours inherently have greater metastatic potential depend-
ing on a variety of specific biochemical properties other
than those of poorly metastatic cells [20]. Our morpho-
logical findings show the existence of a matrix degradation
and cell remodelling mechanism in colorectal adenocarcin-
omas that involves both IPCs and epithelial cells. The re-
modelling and concentration of μ chains in established
cancer areas are extremely relevant factors in the presence
of a particular B1-like cell type. Experiments have shown
that B1 cells are the main source of natural antibodies and
that approximately 10-15% of peritoneal B1 cells are spe-
cific for the membrane phospholipid phosphatidylcholine.
Phosphatidylcholine is the predominant type of phospho-
lipid in malignant and control tissues, and its high levels in
colon tumours is due to its decreased turnover and in-
creased expression [21]. We hypothesise that IPCs play a
role in the pathogenesis of colorectal tumours in the pres-
ence of alterations in tissue lipid composition, although
further studies are necessary to clarify this and whether
our model can be used for other forms of adenocarcinoma.Conclusion
In conclusion the findings of this preliminary morpho-
logical study suggest the presence of membrane disinte-
gration and remodelling mechanisms in the tumours.
The newly-formed membranes expressed high concen-
trations of inflammatory cell receptors that can confer
adhesive properties.
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